Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy

27Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

While combined chemotherapy (CT) with an autophagy inducer and an autophagy inhibitor appears paradoxical, it may provide a more effective perturbation of autophagy pathways. We used two dissimilar cell lines to test the hypothesis that autophagy is the common denominator of cell fate after CT. HA22T cells are characterized by CT-induced apoptosis and use autophagy to prevent cell death, while Huh7.5.1 cells exhibit sustained autophagic morphology after CT. Combined CT and rapamycin treatment resulted in a better combination index (CI) in Huh7.5.1 cells than combined CT and chloroquine, while the reverse was true in HA22T cells. The combination of 3 drugs (triplet drug treatment) had the best CI. After triplet drug treatment, HA22T cells switched from protective autophagy to mitochondrial membrane permeabilization and endoplasmic reticulum stress response-induced apoptosis, while Huh7.5.1 cells intensified autophagic lethality. Most importantly, both cell lines showed activation of Akt after CT, while the triplet combination blocked Akt activation through inhibition of phospholipid lipase D activity. This novel finding warrants further investigation as a broad chemosensitization strategy.

Cite

CITATION STYLE

APA

Chi, K. H., Wang, Y. S., Huang, Y. C., Chiang, H. C., Chi, M. S., Chi, C. H., … Kao, S. J. (2016). Simultaneous activation and inhibition of autophagy sensitizes cancer cells to chemotherapy. Oncotarget, 7(36), 58075–58088. https://doi.org/10.18632/oncotarget.10873

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free